Showing results (971-980 of 9,901) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|April 1, 1996
Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitisG Bogdanovic, P Ljungman, F Wang, et al.Bone Marrow Transplantation|April 1, 1996
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patientsP Ljungman, K Loré, J Aschan, et al.Bone Marrow Transplantation|April 1, 1996
Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipientsC Canpolat, S Culbert, M Gardner, et al.Bone Marrow Transplantation|April 1, 1996
Acquired ciliary abnormalities of nasal mucosa in marrow recipientsC Cordonnier, L Gilain, F Ricolfi, et al.Bone Marrow Transplantation|April 1, 1996
Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequencesS Patri, C Dascalesu, J C Chomel, et al.Bone Marrow Transplantation|April 1, 1996
Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipientsS M King, E F Saunders, M Petric, et al.Bone Marrow Transplantation|April 1, 1996
Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in managementM Iqbal, R J Creger, R M Fox, et al.Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.Bone Marrow Transplantation|January 1, 1989
Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFNF Lauria, R Foà, D Raspadori, et al.Pageof 991